Neuroimmunology News

Jul 10, 2017
Hidden herpes virus may play key role in multiple sclerosis and other brain disorders
The ubiquitous human herpesvirus 6 (HHV-6) may play a critical role in impeding the brain's ability to repair itself in diseases like multiple sclerosis.
Jun 30, 2017
Patients with multiple sclerosis may benefit from over-the-counter therapy
A pilot study suggests over-the-counter antioxidant lipoic acid holds promise in improving multiple sclerosis (MS) patients' lives.The study revealed a 68% improvement over placebo in slowing the rate of whole brain atrophy in patients with secondary progressive MS. The research is published in the journal Neuroimmunology & Neuroinflammation.
Jun 14, 2017
A surprising new link between inflammation and mental illness
New research from Boston Children's Hospital has shed light on the cause of neuropsychiatric symptoms in systemic lupus erythematosus and points to a potential new drug for protecting the brain from the neuropsychiatric effects of lupus and other CNS diseases. The team has published its surprising findings in Nature.
Feb 22, 2017
tDCS combined with computer games at home reduces cognitive symptoms of multiple sclerosis
Patients with multiple sclerosis had better problem solving ability and response time after training with transcranial direct current stimulation (tDCS), according to a new study published February 22, 2017 in Neuromodulation: Technology at the Neural Interface.
Jan 23, 2017
Serum micoRNAs may serve as biomarkers for multiple sclerosis
In a new study published today in JAMA Neurology, researchers have found that serum microRNAs are linked to MRI findings in the brain and spinal cord in patients with multiple sclerosis (MS). These findings suggest that microRNAs could serve as promising biomarkers for monitoring the progression of MS.
Jan 18, 2017
Researchers discover severe side effects of approved multiple sclerosis medication
The multiple sclerosis therapy alemtuzumab can trigger severe, unpredictable side effects, finds by a team led by German researchers published in the journal Lancet Neurology. The team also describes a treatment that successfully curbed the harmful side effects.
Jan 06, 2017
New treatment for a rare form of encephalitis
German researchers have shown for the first time that bortezomib treatment quickly resulted in clinical improvements in patients with severe forms of anti-NMDA receptor encephalitis. Treatment was also associated with a decline in the antibodies responsible for the disease.
Nov 18, 2016
Study links mothers with rheumatoid arthritis and kids with epilepsy
A new study published in the current issue of Neurology shows a link between mothers with rheumatoid arthritis and children with epilepsy. Having a father with rheumatoid arthritis did not have any effect on whether the child would develop epilepsy.
Sep 21, 2016
Drug may prevent, reduce progression of multiple sclerosis in mice
The experimental drug laquinimod may prevent the development or reduce the progression of multiple sclerosis in mice, according to research published in the September 21, 2016, online issue of Neurology® Neuroimmunology & Neuroinflammation.
Jul 13, 2016
Changes uncovered in the gut bacteria of patients with multiple sclerosis
Study finds alterations in the gut microbiomes of treated and untreated multiple sclerosis patients
Next ▶